Severe megaloblastic anemia in a patient with advanced lung adenocarcinoma during treatment with erlotinib: a case report and literature review
Erlotinib is a first-generation, tyrosine kinase inhibitor of the epidermal growth factor receptor (EGFR-TKI) used for the treatment patients with NSCLC. Erlotinib is considered as a safe and effective treatme...
Source: BMC Pulmonary Medicine - Category: Respiratory Medicine Authors: Xin Yan, Jingxian Kong, Jiacheng Wang, Caixia Wang and Hongchang Shen Tags: Case Report Source Type: research
More News: Adenocarcinoma | Anemia | Megaloblastic Anemia | Non-Small Cell Lung Cancer | Respiratory Medicine | Tarceva